Agilent Technologies Inc (A, Financial) has recently shown a stable daily performance with a 0% change, yet the past three months have witnessed a 15.17% decline. With an Earnings Per Share (EPS) of 3.82, investors are keen to understand whether the stock is modestly undervalued and if it holds the potential for a value surge. This valuation analysis aims to explore Agilent Technologies' financial standing and market position to provide a clearer investment picture.
Company Overview
Agilent Technologies Inc, with its rich heritage stemming from Hewlett-Packard, has matured into a forefront entity in life sciences and diagnostics. Its innovative measurement technologies cater to a diverse clientele, including biopharmaceutical, chemical, and advanced materials industries, as well as clinical labs and government organizations. Spanning across the U.S. and China, Agilent Technologies boasts a robust international presence. With a current stock price of $107.46 and a GF Value of $152.36, the company's market capitalization stands at $31.40 billion, indicating a potential undervaluation worth investigating.
Understanding the GF Value
The GF Value is a unique metric that assesses the intrinsic value of a stock, incorporating historical trading multiples, a GuruFocus adjustment factor based on past performance and growth, and future business performance projections. This measure is crucial as it provides an estimated fair trading value for the stock. When the market price significantly deviates from the GF Value Line, it suggests potential overvaluation or undervaluation, influencing future returns. Presently, Agilent Technologies (A, Financial) exhibits signs of modest undervaluation, suggesting that its stock may offer higher long-term returns relative to its business growth.
Financial Strength
Before investing, it's essential to gauge a company's financial strength. Agilent Technologies' cash-to-debt ratio of 0.48 places it below 66.37% of its peers in the Medical Diagnostics & Research industry. Despite this, the company holds a financial strength rating of 7 out of 10, denoting a fair financial condition.
Profitability and Growth
Investing in profitable companies generally carries less risk. Agilent Technologies has maintained profitability for the past decade, with a notable operating margin of 20.2%, surpassing 86.4% of its industry competitors. Such strong profitability is a promising sign for investors.
When it comes to growth, Agilent Technologies' 3-year average annual revenue growth rate of 12% and EBITDA growth rate of 17.9% highlight its potential to create value for shareholders, indicating a solid growth trajectory within the Medical Diagnostics & Research industry.
ROIC vs. WACC
Comparing a company's Return on Invested Capital (ROIC) to its Weighted Average Cost of Capital (WACC) offers insight into its value creation efficiency. Agilent Technologies' ROIC of 13.47 exceeds its WACC of 10.81, suggesting effective capital management and shareholder value generation.
Conclusion
In summary, Agilent Technologies (A, Financial) appears modestly undervalued, with solid financial health and strong profitability. Its growth outpaces more than half of its industry counterparts, making it an attractive option for value investors. To delve deeper into Agilent Technologies' financials, explore the company's 30-Year Financials here.
To discover high-quality companies that may deliver above-average returns, please visit the GuruFocus High Quality Low Capex Screener.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
